UroGen Pharma Ltd. — All Filings
541 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
20-F
3
3/A
4
4/A
424B4
424B5
6-K
8-A12B
8-K
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-25-155503 | Jul 3, 2025 | Jun 30, 2025 |
| SCHEDULE 13G | — | 0001213900-25-054819 | Jun 16, 2025 | — |
| 8-K | 8-K | 0001193125-25-140339 | Jun 13, 2025 | Jun 12, 2025 |
| SCHEDULE 13G | — | 0001085146-25-003449 | Jun 13, 2025 | — |
| 4 | FORM 4 | 0001437749-25-020045 | Jun 11, 2025 | Jun 8, 2025 |
| 144 | — | 0001976408-25-000193 | Jun 10, 2025 | — |
| SCHEDULE 13D/A | — | 0001999371-25-007493 | Jun 9, 2025 | — |
| SCHEDULE 13G/A | — | 0001415889-25-013190 | May 15, 2025 | — |
| 8-K | FORM 8-K | 0001437749-25-015955 | May 12, 2025 | — |
| 10-Q | FORM 10-Q | 0001437749-25-015956 | May 12, 2025 | Mar 31, 2025 |
| SCHEDULE 13G/A | — | 0000902664-25-002237 | May 12, 2025 | — |
| 10-K/A | FORM 10-K/A | 0001437749-25-013839 | Apr 30, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | — | 0001178913-25-000862 | Mar 17, 2025 | — |
| 10-K | FORM 10-K | 0001437749-25-006842 | Mar 10, 2025 | Dec 31, 2024 |
| 8-K | FORM 8-K | 0001437749-25-006757 | Mar 10, 2025 | — |
| 8-K | 8-K | 0001193125-25-030143 | Feb 20, 2025 | Feb 14, 2025 |
| SCHEDULE 13G/A | — | 0000902664-25-000866 | Feb 12, 2025 | — |
| 4 | FORM 4 | 0001437749-25-002688 | Feb 4, 2025 | Jan 31, 2025 |
| 4 | FORM 4 | 0001437749-25-002683 | Feb 4, 2025 | Jan 31, 2025 |
| 4 | FORM 4 | 0001437749-25-002685 | Feb 4, 2025 | Jan 31, 2025 |
| 8-K | 8-K | 0001193125-25-005649 | Jan 14, 2025 | — |
| SC 13D/A | AMENDMENT NO. 1 TO SCHEDULE 13D | 0001213900-24-099322 | Nov 18, 2024 | — |
| SC 13G/A | — | 0001172661-24-005288 | Nov 14, 2024 | — |
| SC 13G/A | UROGEN PHARMA LTD. | 0000902664-24-006499 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-119305 | Nov 14, 2024 | — |
| SC 13G/A | UROGEN PHARMA LTD. | 0000902664-24-006639 | Nov 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001178913-24-003701 | Nov 14, 2024 | — |
| SC 13G/A | COWEN AND COMPANY, LLC | 0001085146-24-005686 | Nov 13, 2024 | — |
| SC 13G | UROGEN PHARMA LTD. | 0000902664-24-006395 | Nov 12, 2024 | — |
| SC 13G | — | 0002012383-24-003700 | Nov 8, 2024 | — |
| 10-Q | FORM 10-Q | 0001437749-24-033454 | Nov 6, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0001193125-24-251712 | Nov 6, 2024 | — |
| SC 13G | — | 0002012383-24-002179 | Oct 24, 2024 | — |
| 8-K | 8-K | 0001193125-24-234808 | Oct 9, 2024 | Oct 7, 2024 |
| 3 | — | 0001415889-24-024930 | Oct 9, 2024 | Oct 8, 2024 |
| 4 | — | 0001415889-24-024932 | Oct 9, 2024 | Oct 8, 2024 |
| 8-K | 8-K | 0001193125-24-224801 | Sep 24, 2024 | Sep 23, 2024 |
| 8-K | 8-K | 0001193125-24-218868 | Sep 13, 2024 | Sep 12, 2024 |
| 4 | FORM 4 | 0001437749-24-029040 | Sep 12, 2024 | Sep 9, 2024 |
| 4 | FORM 4 | 0001437749-24-029036 | Sep 12, 2024 | Sep 9, 2024 |
| 4 | FORM 4 | 0001437749-24-029038 | Sep 12, 2024 | Sep 9, 2024 |
| 144 | — | 0001976408-24-000246 | Sep 10, 2024 | — |
| 8-K | 8-K | 0001193125-24-200993 | Aug 15, 2024 | Aug 14, 2024 |
| 8-K | 8-K | 0001193125-24-199425 | Aug 13, 2024 | — |
| 10-Q | FORM 10-Q | 0001437749-24-026161 | Aug 13, 2024 | Jun 30, 2024 |
| S-8 | FORM S-8 | 0001437749-24-026414 | Aug 13, 2024 | — |
| 4 | FORM 4 | 0001437749-24-025292 | Aug 8, 2024 | Aug 6, 2024 |
| 4 | FORM 4 | 0001437749-24-025293 | Aug 8, 2024 | Aug 6, 2024 |
| 4 | FORM 4 | 0001437749-24-025295 | Aug 8, 2024 | Aug 6, 2024 |
| 4 | FORM 4 | 0001437749-24-025297 | Aug 8, 2024 | Aug 6, 2024 |